GGrantIndex
Sort

51,593 grants matching hepatitis

Murine Model of Human Hepatitis A

$388,750
Stanley M Lemon · Univ Of North Carolina Chapel Hill · R01 · FY2019 · AI

Activation of Atypical PKC by Insulin and Other Agonists

$388,750
Robert V Farese · Roskamp Institute, Inc. · R01 · FY2011 · DK

IL-27 in Vaccine-Elicited Cellular Immunity

$388,750
Ross M Kedl · University Of Colorado Denver · R01 · FY2016 · AI

Fibrinolysis Evaluation in A-TREAT (‘FEAT’ Study)

$388,749
Nigel S Key · Univ Of North Carolina Chapel Hill · R01 · FY2021 · HL

Molecular Characterization of Joubert Syndrome

$388,729
Joseph G Gleeson · University Of California, San Diego · R01 · FY2012 · NS

3/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)

$388,724
Michael Ronan Lucey · University Of Wisconsin-Madison · R01 · FY2024 · AA

Overcoming Resistance Mechanisms in Hedgehog and Myc-amplified Medulloblastoma

$388,690
Ram I Mahato · University Of Nebraska Medical Center · R01 · FY2024 · NS

Development Of Drugs Acting At Adenosine Receptors

$388,688
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2010 · DK

Fidelity, robustness, and diversity in RNA virus evolution and pathogenesis

$388,675
Adam Lauring · University Of Michigan At Ann Arbor · R01 · FY2020 · AI

Regulation of Kidney-Specific Gene Expression

$388,660
Peter Igarashi · University Of Minnesota · R37 · FY2016 · DK

Disposition of Flavonoids via Metabolic Interplay

$388,652
Ming Hu · University Of Houston · R01 · FY2011 · GM

In vitro Expression of Hormone Regulated Genes: COUP-TFII in CDH

$388,638
Ming-Jer Tsai · Baylor College Of Medicine · R01 · FY2007 · HD

Role of Intestinal Microbiota in Dyslipidemia and Atherosclerosis Induced by Ambient Ultrafine Particles

$388,616
Jesus Antonio Araujo · University Of California Los Angeles · R01 · FY2021 · ES

The role of endocannabinoids in circadian disruption induced metabolic dysregulation

$388,584
Ilia Nicholas Karatsoreos · Washington State University · R01 · FY2019 · DK

Stem Cell Therapy and Postinfarction LV Remodeling

$388,582
Jianyi Zhang · University Of Minnesota · R01 · FY2008 · HL

Role of Sphingomyelin in Lipoprotein Metabolism

$388,575
Papasani V Subbaiah · University Of Illinois At Chicago · R01 · FY2012 · HL

Cyclin D1/CDK4 Complex in Hepatocyte Proliferation

$388,571
Jeffrey H Albrecht · University Of Minnesota · R01 · FY2016 · DK

Disposition of Flavonoids via Metabolic Interplay

$388,548
Ming Hu · University Of Houston · R01 · FY2012 · GM

Evaluating risk factors for cirrhosis progression and response to statin therapy among a cohort of patients with cirrhosis

$388,501
David Seth Goldberg · University Of Miami School Of Medicine · U01 · FY2025 · DK

Investigating the effects of novel medications for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV.

$388,500
Lorenzo Leggio · National Institute On Drug Abuse · ZIA · FY2023 · DA

A systems-metabolism approach to identify mitochondria-dependent vulnerabilities in colorectal cancer

$388,489
David Francis Kashatus · University Of Virginia · U54 · FY2025 · CA

Oxysterols, Atherosclerosis and Metabolic Syndrome

$388,488
Daniel S Ory · Washington University · P50 · FY2009 · HL

Multiparametric ultrasound imaging for early detection of nonalcoholic fatty liver disease

$388,482
Kenneth Hoyt · Texas Engineering Experiment Station · R01 · FY2024 · DK

Geles: A Novel Imaging Informatics System for Generalizable Lesion Identification in Neuroendocrine Tumors

$388,467
Fuyong Xing · University Of Colorado Denver · R21 · FY2023 · CA

A brain-liver circuit in regulation of alcoholic liver disease

$388,448
Allison W. Xu · University Of California, San Francisco · R01 · FY2015 · AA